Items where Author is "Nyang'wa, Bern-Thomas"
Number of items: 6.
2022
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis. (2022)
Berry, Catherine; du Cros, Philipp; Fielding, Katherine; Gajewski, Suzanne; Kazounis, Emil; McHugh, Timothy D; Merle, Corinne; Motta, Ilaria; Moore, David AJ; Nyang'wa, Bern-Thomas
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis. (2022)
Nyang'wa, Bern-Thomas; Berry, Catherine; Kazounis, Emil; Motta, Ilaria; Parpieva, Nargiza; Tigay, Zinaida; Solodovnikova, Varvara; Liverko, Irina; Moodliar, Ronelle; Dodd, Matthew; Ngubane, Nosipho; Rassool, Mohammed; McHugh, Timothy D; Spigelman, Melvin; Moore, David AJ; Ritmeijer, Koert; du Cros, Philipp; Fielding, Katherine; TB-PRACTECAL Study Collaborators
picture_as_pdf
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis. (2022)
Sweeney, Sedona; Berry, Catherine; Kazounis, Emil; Motta, Ilaria; Vassall, Anna; Dodd, Matthew; Fielding, Katherine; Nyang'wa, Bern-Thomas
2020
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy. (2020)
Sweeney, Sedona; Gomez, Gabriela; Kitson, Nichola; Sinha, Animesh; Yatskevich, Natalia; Staples, Suzanne; Moodliar, Ronelle; Motlhako, Sharon; Maloma, Matshepo; Rassool, Mohammed; Ngubane, Nosipho; Ndlovu, Ella; Nyang'wa, Bern-Thomas